LH Labcorp
NYSE · SEC CIK 920148 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $13.70M 20 sales by 10 insiders
- Filings on record
- 414 since 2021-08-03, latest 2026-09-03 08:21
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Schechter Adam H | Pres, CEO, Dir | — | $8.44M |
| Parham Richelle P | Dir | — | $1.78M |
| Wilkinson Peter J | SVP, CAO | — | $1.06M |
| ANDERSON KERRII B | Dir | — | $954.1K |
| Caveney Brian J | EVP, CMO, CSO, Pres of ED | — | $429.5K |
| Meltzer Jonathan C | EVP, Ops | — | $298.8K |
| Summy Amy B. | EVP, CMO | — | $283.4K |
| Kyle Kathryn W | EVP, CLO | — | $227.4K |
| van der Vaart Sandra D | EVP, Corp. Affairs | — | $156.0K |
| Vaughn Bryan T | EVP, Pres, Diagnostics | — | $67.0K |
Transactions 566
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-10 | 2026-02-06+ | LH | Kyle Kathryn W | EVP, CLO | F - Tax | $275.60 | -122 | 3,171 | -4% | -$33.6K |
| DM | 2026-02-10 | 2026-02-06+ | LH | Summy Amy B. | EVP, CMO | F - Tax | $275.72 | -172 | 5,432 | -3% | -$47.4K |
| DM | 2026-02-10 | 2026-02-06+ | LH | Summy Amy B. | EVP, CMO | M - OptEx | — | +445 | 5,654 | +9% | — |
| DM | 2026-02-10 | 2026-02-06+ | LH | van der Vaart Sandra D | EVP, Corp. Affairs | M - OptEx | — | +740 | 2,690 | +38% | — |
| DM | 2026-02-10 | 2026-02-06+ | LH | van der Vaart Sandra D | EVP, Corp. Affairs | F - Tax | $275.67 | -194 | 2,589 | -7% | -$53.5K |
| DM | 2026-02-10 | 2026-02-06+ | LH | Schechter Adam H | Pres, CEO, Dir | F - Tax | $275.58 | -2,667 | 92.6K | -3% | -$735.0K |
| DM | 2026-02-10 | 2026-02-06+ | LH | Schechter Adam H | Pres, CEO, Dir | M - OptEx | — | +7,709 | 94.0K | +9% | — |
| 2025-11-13 | 2025-11-11 | LH | Schechter Adam H | Pres, CEO, Dir | S - Sale | $262.75 | -5,745 | 87.6K | -6% | -$1.51M | |
| D | 2025-11-04 | 2025-11-03 | LH | Bailey Megan D. | EVP, Pres, Central Labs, Intl | F - Tax | $257.84 | -179 | 3,594 | -5% | -$46.2K |
| D | 2025-11-04 | 2025-11-01 | LH | Bailey Megan D. | EVP, Pres, Central Labs, Intl | M - OptEx | — | +370 | 3,773 | +11% | — |
| 2025-11-04 | 2025-10-31 | LH | Parham Richelle P | Dir | S - Sale | $254.28 | -7,009 | 2,469 | -74% | -$1.78M | |
| D | 2025-11-04 | 2025-11-03 | LH | Oyegunwa Akinbolade | EVP, CIO, CTO | F - Tax | $257.84 | -107 | 3,727 | -3% | -$27.6K |
| D | 2025-11-04 | 2025-11-01 | LH | Oyegunwa Akinbolade | EVP, CIO, CTO | M - OptEx | — | +370 | 3,834 | +11% | — |
| D | 2025-08-15 | 2025-08-13 | LH | van der Vaart Sandra D | EVP, CLO | M - OptEx | $131.43 | +3,903 | 6,177 | +172% | +$513.0K |
| D | 2025-08-15 | 2025-08-13 | LH | van der Vaart Sandra D | EVP, CLO | S - Sale+OE | $271.42 | -3,903 | 2,274 | -63% | -$1.06M |
| 2025-08-13 | 2025-08-11 | LH | Schechter Adam H | Pres, CEO, Dir | S - Sale | $266.78 | -5,643 | 93.3K | -6% | -$1.51M | |
| 2025-08-01 | 2025-07-30 | LH | Gilliland Dwight Gary | Dir | S - Sale | $264.95 | -2,000 | 6,656 | -23% | -$529.9K | |
| M | 2025-07-31 | 2025-07-29 | LH | Wilkinson Peter J | SVP, CAO | S - Sale | $261.02 | -202 | 1,852 | -10% | -$52.7K |
| 2025-07-28 | 2025-07-24 | LH | ANDERSON KERRII B | Dir | S - Sale | $280.00 | -3,500 | 8,666 | -29% | -$980.0K | |
| 2025-07-28 | 2025-07-24 | LH | ANDERSON KERRII B | Dir | S - Sale | $280.00 | -3,500 | 8,666 | -29% | -$980.0K | |
| 2025-07-02 | 2025-07-01 | LH | ANDERSON KERRII B | Dir | S - Sale | $265.00 | -500 | 12.2K | -4% | -$132.5K | |
| 2025-06-12 | 2025-06-11 | LH | ANDERSON KERRII B | Dir | S - Sale | $260.00 | -500 | 12.7K | -4% | -$130.0K | |
| 2025-06-05 | 2025-06-03 | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | S - Sale | $247.00 | -2,000 | 30.1K | -6% | -$494.0K | |
| 2025-05-13 | 2025-05-12 | LH | Schechter Adam H | Pres, CEO, Dir | S - Sale | $248.73 | -6,105 | 99.0K | -6% | -$1.52M | |
| 2025-05-05 | 2025-05-01 | LH | van der Vaart Sandra D | EVP, CLO | S - Sale | $238.36 | -1,900 | 2,244 | -46% | -$452.9K | |
| 2025-05-05 | 2025-05-01 | LH | Wilkinson Peter J | SVP, CAO | S - Sale | $242.27 | -829 | 2,054 | -29% | -$200.8K | |
| DM | 2025-04-03 | 2025-04-01 | LH | Bailey Megan D. | EVP, Pres, Central Labs, Intl | M - OptEx | — | +4,287 | 3,471 | New | — |
| DM | 2025-04-03 | 2025-04-01 | LH | Bailey Megan D. | EVP, Pres, Central Labs, Intl | F - Tax | $232.65 | -1,614 | 3,403 | -32% | -$375.5K |
| 2025-03-31 | 2025-03-27 | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | A - Grant | $0.00 | +4,840 | 34.2K | +16% | $0 | |
| 2025-03-31 | 2025-03-27 | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | F - Tax | $231.67 | -2,109 | 32.1K | -6% | -$488.6K | |
| 2025-03-31 | 2025-03-27 | LH | Oyegunwa Akinbolade | EVP, CIO, CTO | F - Tax | $231.67 | -198 | 3,464 | -5% | -$45.9K | |
| 2025-03-31 | 2025-03-27 | LH | Oyegunwa Akinbolade | EVP, CIO, CTO | A - Grant | $0.00 | +688 | 3,662 | +23% | $0 | |
| 2025-03-31 | 2025-03-28 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | S - Sale | $231.67 | -2,635 | 4,960 | -35% | -$610.5K | |
| 2025-03-31 | 2025-03-27 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | A - Grant | $0.00 | +4,840 | 9,800 | +98% | $0 | |
| 2025-03-31 | 2025-03-27 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | F - Tax | $231.67 | -2,205 | 7,595 | -22% | -$510.8K | |
| 2025-03-31 | 2025-03-27 | LH | BERBERIAN LANCE | EVP, Special Advisor, Strategy | F - Tax | $231.67 | -1,353 | 18.7K | -7% | -$313.4K | |
| 2025-03-31 | 2025-03-27 | LH | BERBERIAN LANCE | EVP, Special Advisor, Strategy | A - Grant | $0.00 | +3,325 | 20.0K | +20% | $0 | |
| 2025-03-31 | 2025-03-27 | LH | Summy Amy B. | EVP, CMO | A - Grant | $0.00 | +2,077 | 6,622 | +46% | $0 | |
| 2025-03-31 | 2025-03-27 | LH | Summy Amy B. | EVP, CMO | F - Tax | $231.67 | -562 | 6,060 | -8% | -$130.2K | |
| 2025-03-31 | 2025-03-28 | LH | Summy Amy B. | EVP, CMO | S - Sale | $231.67 | -758 | 5,302 | -13% | -$175.6K | |
| 2025-03-31 | 2025-03-27 | LH | Schechter Adam H | Pres, CEO, Dir | A - Grant | $0.00 | +30.5K | 118.7K | +35% | $0 | |
| 2025-03-31 | 2025-03-27 | LH | Schechter Adam H | Pres, CEO, Dir | F - Tax | $231.67 | -13.6K | 105.1K | -11% | -$3.15M | |
| 2025-03-31 | 2025-03-27 | LH | van der Vaart Sandra D | EVP, CLO | F - Tax | $231.67 | -1,352 | 4,144 | -25% | -$313.2K | |
| 2025-03-31 | 2025-03-27 | LH | van der Vaart Sandra D | EVP, CLO | A - Grant | $0.00 | +3,325 | 5,496 | +153% | $0 | |
| 2025-03-31 | 2025-03-27 | LH | Wilkinson Peter J | SVP, CAO | A - Grant | $0.00 | +1,249 | 3,242 | +63% | $0 | |
| 2025-03-31 | 2025-03-27 | LH | Wilkinson Peter J | SVP, CAO | F - Tax | $231.67 | -359 | 2,883 | -11% | -$83.2K | |
| 2025-03-31 | 2025-03-27 | LH | EISENBERG GLENN A | EVP | F - Tax | $231.67 | -3,630 | 37.9K | -9% | -$841.0K | |
| 2025-03-31 | 2025-03-27 | LH | EISENBERG GLENN A | EVP | A - Grant | $0.00 | +8,305 | 41.5K | +25% | $0 | |
| 2025-03-07 | 2025-03-05 | LH | ANDERSON KERRII B | Dir | S - Sale | $255.63 | -500 | 13.2K | -4% | -$127.8K | |
| D | 2025-03-04 | 2025-02-28 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | S - Sale+OE | $249.23 | -5,339 | 4,960 | -52% | -$1.33M |
| D | 2025-03-04 | 2025-02-28 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | M - OptEx | $131.43 | +3,903 | 10.3K | +61% | +$513.0K |
| 2025-02-27 | 2025-02-25 | LH | van der Vaart Sandra D | EVP, CLO | S - Sale | $251.30 | -1,314 | 2,171 | -38% | -$330.2K | |
| 2025-02-26 | 2025-02-24 | LH | Summy Amy B. | EVP, CMO | S - Sale | $250.40 | -226 | 4,544 | -5% | -$56.6K | |
| D | 2025-02-20 | 2022-08-01 | LH | Wilkinson Peter J | SVP, CAO | G - Gift | $0.00 | -351 | 1,993 | -15% | $0 |
| D | 2025-02-20 | 2025-02-18 | LH | Wilkinson Peter J | SVP, CAO | S - Sale+OE | $246.10 | -1,413 | 1,993 | -41% | -$347.7K |
| D | 2025-02-20 | 2025-02-18 | LH | Wilkinson Peter J | SVP, CAO | M - OptEx | $163.63 | +1,413 | 3,406 | +71% | +$231.2K |
| D | 2025-02-13 | 2025-02-11 | LH | BERBERIAN LANCE | EVP, Special Advisor, Strategy | M - OptEx | — | +323 | 16.8K | +2% | — |
| D | 2025-02-13 | 2025-02-11 | LH | BERBERIAN LANCE | EVP, Special Advisor, Strategy | F - Tax | $245.14 | -86 | 16.7K | -0.5% | -$21.1K |
| D | 2025-02-13 | 2025-02-11 | LH | Oyegunwa Akinbolade | EVP, CIO, CTO | F - Tax | $245.14 | -42 | 2,974 | -1% | -$10.3K |
| D | 2025-02-13 | 2025-02-11 | LH | Oyegunwa Akinbolade | EVP, CIO, CTO | M - OptEx | — | +134 | 3,016 | +5% | — |
| D | 2025-02-13 | 2025-02-11 | LH | EISENBERG GLENN A | EVP | F - Tax | $245.14 | -213 | 33.2K | -0.6% | -$52.2K |
| D | 2025-02-13 | 2025-02-11 | LH | EISENBERG GLENN A | EVP | M - OptEx | — | +807 | 33.5K | +2% | — |
| D | 2025-02-13 | 2025-02-11 | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | F - Tax | $245.14 | -136 | 29.3K | -0.5% | -$33.3K |
| D | 2025-02-13 | 2025-02-11 | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | M - OptEx | — | +473 | 29.5K | +2% | — |
| D | 2025-02-13 | 2025-02-11 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | F - Tax | $245.14 | -134 | 6,396 | -2% | -$32.8K |
| D | 2025-02-13 | 2025-02-11 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | M - OptEx | — | +473 | 6,530 | +8% | — |
| D | 2025-02-13 | 2025-02-11 | LH | Wilkinson Peter J | SVP, CAO | M - OptEx | — | +123 | 2,385 | +5% | — |
| D | 2025-02-13 | 2025-02-11 | LH | Wilkinson Peter J | SVP, CAO | F - Tax | $245.14 | -41 | 2,344 | -2% | -$10.1K |
| D | 2025-02-13 | 2025-02-11 | LH | Summy Amy B. | EVP, CMO | M - OptEx | — | +201 | 4,826 | +4% | — |
| D | 2025-02-13 | 2025-02-11 | LH | Summy Amy B. | EVP, CMO | F - Tax | $245.14 | -55 | 4,770 | -1% | -$13.5K |
| D | 2025-02-13 | 2025-02-11 | LH | van der Vaart Sandra D | EVP, CLO | F - Tax | $245.14 | -86 | 3,485 | -2% | -$21.1K |
| D | 2025-02-13 | 2025-02-11 | LH | van der Vaart Sandra D | EVP, CLO | M - OptEx | — | +323 | 3,571 | +10% | — |
| D | 2025-02-13 | 2025-02-11 | LH | Schechter Adam H | Pres, CEO, Dir | S - Sale+OE | $244.62 | -6,121 | 86.4K | -7% | -$1.50M |
| D | 2025-02-13 | 2025-02-11 | LH | Schechter Adam H | Pres, CEO, Dir | M - OptEx | — | +2,963 | 89.4K | +3% | — |
| D | 2025-02-13 | 2025-02-11 | LH | Schechter Adam H | Pres, CEO, Dir | F - Tax | $245.14 | -1,226 | 88.2K | -1% | -$300.5K |
| DM | 2025-02-10 | 2025-02-06+ | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | F - Tax | $247.04 | -403 | 6,057 | -6% | -$99.6K |
| DM | 2025-02-10 | 2025-02-06+ | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | M - OptEx | — | +1,424 | 5,779 | +33% | — |
| DM | 2025-02-10 | 2025-02-06+ | LH | Summy Amy B. | EVP, CMO | M - OptEx | — | +447 | 4,542 | +11% | — |
| DM | 2025-02-10 | 2025-02-06+ | LH | Summy Amy B. | EVP, CMO | F - Tax | $247.03 | -141 | 4,468 | -3% | -$34.8K |
| D | 2025-02-10 | 2025-02-06 | LH | Wengel Kathryn E | Dir | M - OptEx | — | +944 | 3,236 | +41% | — |
| DM | 2025-02-10 | 2025-02-06+ | LH | Bailey Megan D. | EVP, Pres, Central Labs, Intl | M - OptEx | — | +471 | 752 | +168% | — |
| DM | 2025-02-10 | 2025-02-06+ | LH | Bailey Megan D. | EVP, Pres, Central Labs, Intl | F - Tax | $246.85 | -177 | 730 | -20% | -$43.7K |
| D | 2025-02-10 | 2025-02-06 | LH | Kliphouse Kirsten Marie | Dir | M - OptEx | — | +944 | 2,263 | +72% | — |
| D | 2025-02-10 | 2025-02-06 | LH | Wang Julia Aijun | CFO, EVP | F - Tax | $247.74 | -336 | 557 | -38% | -$83.2K |
| D | 2025-02-10 | 2025-02-06 | LH | Wang Julia Aijun | CFO, EVP | M - OptEx | — | +893 | 893 | New | — |
| DM | 2025-02-10 | 2025-02-06+ | LH | EISENBERG GLENN A | EVP | F - Tax | $247.04 | -489 | 32.0K | -2% | -$120.8K |
| DM | 2025-02-10 | 2025-02-06+ | LH | EISENBERG GLENN A | EVP | M - OptEx | — | +1,851 | 32.9K | +6% | — |
| D | 2025-02-10 | 2025-02-06 | LH | Rothman Paul | Dir | M - OptEx | — | +944 | 1,674 | +129% | — |
| DM | 2025-02-10 | 2025-02-06+ | LH | BERBERIAN LANCE | EVP, Special Advisor, Strategy | M - OptEx | — | +710 | 16.3K | +5% | — |
| DM | 2025-02-10 | 2025-02-06+ | LH | BERBERIAN LANCE | EVP, Special Advisor, Strategy | F - Tax | $247.01 | -188 | 16.4K | -1% | -$46.4K |
| D | 2025-02-10 | 2025-02-06 | LH | Davis Jeffrey A. | Dir | M - OptEx | — | +944 | 4,563 | +26% | — |
| D | 2025-02-10 | 2025-02-06 | LH | ANDERSON KERRII B | Dir | M - OptEx | — | +944 | 13.7K | +7% | — |
| DM | 2025-02-10 | 2025-02-06+ | LH | van der Vaart Sandra D | EVP, CLO | F - Tax | $247.03 | -196 | 3,248 | -6% | -$48.4K |
| DM | 2025-02-10 | 2025-02-06+ | LH | van der Vaart Sandra D | EVP, CLO | M - OptEx | — | +740 | 3,090 | +31% | — |
| DM | 2025-02-10 | 2025-02-06+ | LH | GRAHAM ANITA Z | EVP, CHRO | F - Tax | $247.00 | -237 | 500 | -32% | -$58.5K |
| DM | 2025-02-10 | 2025-02-06+ | LH | GRAHAM ANITA Z | EVP, CHRO | M - OptEx | — | +695 | 869 | +399% | — |
| D | 2025-02-10 | 2025-02-06 | LH | Kong Garheng | Dir | M - OptEx | — | +944 | 12.8K | +8% | — |
| DM | 2025-02-10 | 2025-02-06+ | LH | Oyegunwa Akinbolade | EVP, CIO, CTO | F - Tax | $247.08 | -113 | 2,784 | -4% | -$27.9K |
| DM | 2025-02-10 | 2025-02-06+ | LH | Oyegunwa Akinbolade | EVP, CIO, CTO | M - OptEx | — | +329 | 2,846 | +13% | — |
| D | 2025-02-10 | 2025-02-06 | LH | Parham Richelle P | Dir | M - OptEx | — | +944 | 9,478 | +11% | — |
Purchase Sale Sale after option exercise All abbreviations